Effects of berberine on angiotensin-converting enzyme and NO/cGMP system in vessels

Vascular Pharmacology

Volumn 39, Issue 6, 2002, Pages 281-286

  Kang, Dae Gill ^a   Sohn, Eun Jin ^a   Kwon, Eui Kwang ^a   Han, Jong Hyun ^a   Oh, Hyuncheol ^a   Lee, Ho Sub ^a  

^a Wonkwang University   (South Korea)

Author keywords

Angiotensin converting enzyme; Berberine; NO cGMP; Vasorelaxation

Indexed keywords

BERBERINE; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE; NITRIC OXIDE; PHENYLEPHRINE; SPASMOLYTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL TONE; COLORIMETRY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; HYPERTENSION; IC 50; INHIBITION KINETICS; ISOLATED ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE RELAXATION; SPECTROFLUOROMETRY; STATISTICAL SIGNIFICANCE; THORACIC AORTA;

EID: 0038309889     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1537-1891(03)00005-3     Document Type: Article

References (34)

1. Al-Qattan K.K., Alnaqeeb M.A., Ali M. The antihypertensive effect of garlic (Allium sativum) in the rat two-kidney, one-clip Goldblatt model. J. Ethnopharmacol. 66:1999;217-222.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
3. Carson P.E. Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure. Am. Heart J. 140(3):2000;361-366.
4. Chen C.H., Lin J.Y. Inhibition of angiotensin I-converting enzyme by tetrahydroxyxanthones isolated from Tripterospermum lanceolatum. J. Nat. Prod. 55(5):1992;691-695.
5. Chiou W.F., Yen M.H., Chen C.F. Mechanism of vasodilatory effect of berberine in rat mesenteric artery. Eur. J. Pharmacol. 204(1):1991;35-40.
6. Chiou W.F., Chen J., Chen C.F. Relaxation of corpus cavernosum and raised intracavernous pressure by berberine in rabbit. Br. J. Pharmacol. 125(8):1998;1677-1684.
7. Chiou W.F., Chang P.C., Chou C.J., Chen C.F. Protein constituent contributes to the hypotensive and vasorelaxant activities of Cordyceps sinensis. Life Sci. 66(14):2000;1369-1376.
8. Chun Y.T., Yip T.T., Lau K.L., Kong Y.C., Sankawa U. A biochemical study on the hypotensive effect of berberine in rats. Gen. Pharmacol. 10(3):1979;177-182.
9. Goto H., Sakakibara I., Shimada Y., Kasahara Y., Terasawa K. Vasodilator effect of extract prepared from Uncaria ramulus on isolated rat aorta. Am. J. Chin. Med. 28(2):2000;197-203.
10. Guyton A.C., Hall J. Textbook of Medical Physiology. 9th ed. 1996;227-237 Sauders, Pennsylvania.
11. Hansen K., Nymann U., Smitt U.W., Adsersen A., Gudiksen L., Rajasekharan S., Pushpangadan P. In vitro screening of traditional medicines for anti-hypertensive effect based on inhibition of the angiotensin-converting enzyme. J. Ethnopharmacol. 48:1995;43-51.
12. Hayashi K., Nunami K., Sakai K., Ozaki Y., Kato J., Kinashi K., Yoneda N. Studies on angiotensin-converting enzyme inhibitors: II. Syntheses and angiotensin-converting enzyme inhibitory activities of carboxyethylcarbamoyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives. Chem. Pharmacol. Bull. (Tokyo). 31(10):1983;3553-3561.
13. Hebert L.A., Falkenhain M.E., Nahman N.S. Jr., Cosio F.G., O'Dorisio T.M. Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy. Am. J. Nephrol. 19(1):1999;1-6.
14. Huang W.M., Wu Z.D., Gan Y.Q. Effects of berberine on ischemic ventricular arrhythmia. Zhonghua Xin Xue Guan Bing Za Zhi. 17(5):1989;300-301.
15. Inokuchi J., Okabe H., Yamauchi T., Nagamatsu A., Nonaka G., Nishioka I. Antihypertensive substance in seeds of Areca catechu L. Life Sci. 38:1986;1375-1382.
16. Kamata K., Noguchi M., Nagai M. Hypotensive effects of lithospermic acid B isolated from the extract of Salviae miltiorrhiza radix in the rat. Gen. Pharmacol. 25(1):1994;69-73.
17. Kim S.Z., Kim S.H., Park J.K., Koh G.Y., Cho K.W. Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum. J. Urol. 159(5):1998;1741-1746.
18. Kim S.H., Kang K.W., Kim K.W., Kim N.D. Procyanidins in crataegus extract evoke endothelium-dependent vasorelaxation in rat aorta. Life Sci. 67(2):2000;121-131.
19. Ko W.H., Yao X.Q., Lau C.W., Law W.I., Chen Z.Y., Kwok W., Ho K., Huang Y. Vasorelaxant and antiproliferative effects of berberine. Eur. J. Pharmacol. 399(2-3):2000;187-196.
20. Lee M.A., Paul M., Bohm M., Ganten D. Effects of angiotensin-converting enzyme inhibitors on tissue renin-angiotensin systems. Am. J. Cardiol. 70(10):1992;12C-19C.
21. Miller M.A., Texter M., Gmerek A., Robbins J., Shurzinske L., Canter D. Quinapril hydrochloride effects on renal function in patients with renal dysfunction and hypertension: a drug-withdrawal study. Cardiovasc. Drugs Ther. 8(2):1994;271-275.
22. Mirska I., Kedzia H., Kowalewski Z., Kedzia W. The effect of berberine sulfate on healthy mice infected with Candida albicans. Arch. Immunol. Ther. Exp. (Warsz). 20(6):1972;921-929.
23. Nishino H., Kitagawa K., Fujiki H., Iwashima A. Berberine sulfate inhibits tumor-promoting activity of teleocidin in two-stage carcinogenesis on mouse skin. Oncology. 43(2):1986;131-134.
24. Ondetti M.A., Rubin B., Cushman D.W. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science. 196(4288):1977;441-444.
25. Pedraza-Chaverri J., Tapia E., Medina-Campos O., Granados M. de L.A., Franco M. Garlic prevents hypertension induced by chronic inhibition of nitric oxide synthesis. Life Sci. 62(6):1998;PL 71-PL 77.
26. Sabir M., Bhide N.K. Study of some pharmacological actions of berberine. Indian J. Physiol. Pharmacol. 15(3):1971;111-132.
27. Santos R.A., Krieger E.M., Greene L.J. An improved fluorometric assay of rat serum and plasma converting enzyme. Hypertension. 7(2):1985;244-252.
28. Shlipak M.G., Browner W.S., Noguchi H., Massie B., Frances C.D., McClellan M. Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction. Am. J. Med. 110(6):2001;425-433.
29. Tanner M.A., Bu X., Steimle J.A., Myers P.R. The direct release of nitric oxide by gypenosides derived from the herb Gynostemma pentaphyllum. Nitric Oxide. 3(5):1999;359-365.
30. Ueno H., Horie S., Nishi Y., Shogawa H., Kawasaki M., Suzuki S., Hayashi T., Arisawa M., Shimizu M., Yoshizaki M., Mirita N. Chemical and pharmaceutical studies on medicinal plants in Paraguay. Geranii, an angiotensin-converting enzyme inhibitor from 'Paraparai mi,' Phyllanthanthus niruri. J. Nat. Prod. 51:1988;357-359.
31. White R.M., Rivera C.O., Davison C.B. Differential contribution of endothelial function to vascular reactivity in conduit and resistance arteries from deoxycorticosterone-salt hypertensive rats. Hypertension. 27(6):1996;1245-1253.
32. Xie Y.W., Ming D.S., Xu H.X., Dong H., But P.P. Vasorelaxing effects of Caesalpinia sappan involvement of endogenous nitric oxide. Life Sci. 67(15):2000;1913-1918.
33. Yamamoto K., Takase H., Abe K., Saito Y., Suzuki A. Pharmacological studies on antidiarrheal effects of a preparation containing berberine and geranii herba. Nippon Yakurigaku Zasshi. 101(3):1993;169-175.
34. Zeng X., Zeng X. Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC. Biomed. Chromatogr. 13(7):1999;442-444.